Dengvaxia

Dengvaxia is a vaccine designed to prevent dengue fever, a mosquito-borne viral infection. It is administered subcutaneously and is suitable for individuals at risk of exposure to the dengue virus.

Dengvaxia is used to protect against dengue fever, which is caused by the dengue virus. This vaccine is typically recommended for individuals living in or traveling to areas where dengue is endemic. It works by stimulating the immune system to produce antibodies against the dengue virus, thereby reducing the risk of infection.

Common effects of Dengvaxia may include mild to moderate injection site reactions such as pain, redness, or swelling. Some individuals may also experience general symptoms like headache, fatigue, or muscle pain. These effects are usually temporary and resolve on their own.

Dengvaxia should be administered by healthcare professionals. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine. Individuals with weakened immune systems should consult their doctor before vaccination.

Dengvaxia may interact with other vaccines or medications. It is advisable to discuss any current medications or recent vaccinations with a healthcare provider before receiving Dengvaxia. Avoid taking immunosuppressive drugs around the time of vaccination.